You are viewing: GCC Countries ECMO Machines Market analysis
Part of: ECMO Machines Market (Global)

The GCC Countries ECMO Machines Market was valued at $52.05 Million in 2025 and projected to reach to $67.98 Million by 2030, representing a compound annual growth rate of 5.5%. The GCC Countries ECMO machines market is poised for sustained growth through 2030, driven by expanding healthcare infrastructure investments and increasing adoption of advanced life support technologies.

GCC Countries ECMO Machines Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

GCC Countries ECMO Machines Market Trends and Insights

  • Rest Of Europe represents a significant segment within the broader European ECMO market, driven by increasing adoption of extracorporeal membrane oxygenation technology in critical care settings across multiple countries.
  • The region's growth trajectory reflects rising demand for advanced cardiac and respiratory support solutions in hospitals and specialized medical centers. Rest Of Europe's ECMO market is expanding at a compound annual growth rate of 5.5%, indicating sustained investment in life-support technologies and improved healthcare infrastructure.
  • Between 2025 and 2030, Rest Of Europe is expected to see incremental market expansion fueled by aging populations, higher prevalence of cardiac and pulmonary conditions, and enhanced clinical adoption of ECMO protocols.
  • Rest Of Europe's healthcare systems are increasingly recognizing ECMO as a critical intervention for severe heart and lung failure cases, supporting market penetration and revenue growth throughout the forecast period..

Key Market Statistics

  • CAGR (2025-2030) 5.5% CAGR
  • Market Size, 2025 ~USD 52.05 Million
  • Forecast, 2030 ~USD 67.98 Million
  • Country GCC Countries

GCC Countries ECMO Machines Market Overview

Market Size & Growth :

The GCC Countries ECMO machines market is valued at $52.05 million in 2025, with a projected growth to $67.98 million by 2030, representing a steady CAGR of 5.5% throughout the forecast period.

Regional Healthcare Investment :

GCC nations are significantly investing in advanced critical care infrastructure, with Saudi Arabia, UAE, and Qatar leading adoption of ECMO technology in their tertiary care centers and specialized cardiac facilities.

Clinical Demand Drivers :

Rising prevalence of cardiac and respiratory complications, coupled with increasing patient volumes in ICU settings across GCC hospitals, is driving demand for extracorporeal membrane oxygenation systems.

Competitive Landscape :

The GCC ECMO market features both established global manufacturers and emerging regional distributors, with growing partnerships between international device makers and local healthcare providers.

GCC Countries ECMO Machines Market Dynamics

  • Major healthcare systems in Saudi Arabia, UAE, and Qatar are prioritizing critical care capabilities, creating strong demand for ECMO devices in cardiac surgery, respiratory failure management, and emergency medicine applications. Market expansion will be supported by rising healthcare expenditure, growing medical tourism, and enhanced clinical training programs across GCC institutions.
  • The region's focus on achieving healthcare excellence and reducing patient mortality rates in critical conditions positions ECMO technology as a strategic priority, with manufacturers establishing stronger regional presence and localized support networks..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Rest Of Europe's ECMO machines market is valued at $52.05 million in 2025 and is forecast to grow to $67.98 million by 2030.
    • Rest Of Europe is experiencing a 5.5% compound annual growth rate, reflecting steady adoption of extracorporeal membrane oxygenation technology.
    • Rest Of Europe's market growth is driven by aging demographics, increased cardiac and respiratory disease prevalence, and enhanced clinical protocols.
    • Rest Of Europe represents a key regional segment within Europe's broader ECMO market, with sustained investment in critical care infrastructure.

    ECMO Machines Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) (Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.8% from 2025 to 2030
    Largest Segment ADULT PATIENTS (Patient Type)
    Market Size Base Year (Billions) ~USD 0.65 (2025)
    Revenue Forecast (Billions) ~USD 0.86 (2030)
    Segments Covered Product, Type, Modality, Patient Type, Application, End User

    GCC Countries ECMO Machines Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Components
    • Machines

    By Type

    • Accessories
    • Cannulas
    • Controllers
    • Oxygenators
    • Pumps

    By Modality

    • Arteriovenous Ecmo
    • Venoarterial Ecmo
    • Venovenous Ecmo

    By Patient Type

    • Adult Patients
    • Neonates
    • Pediatric Patients

    By Application

    • Cardiac Applications
    • Extracorporeal Cardiopulmonary Resuscitation (Ecpr)
    • Respiratory Applications

    By End User

    • Academic & Research Institutions
    • Hospitals
    • Specialty Clinics

    Target Audience

    • Medical Device Manufacturers : ECMO device makers need GCC-specific market data to assess market potential, identify distribution partnerships, and develop localized go-to-market strategies for the region.
    • Healthcare Facility Operators : Hospital administrators and ICU directors in GCC countries require market insights to justify ECMO investments, benchmark against regional peers, and plan critical care expansion.
    • Healthcare Investors & PE Firms : Investment professionals evaluating healthcare opportunities in GCC nations need accurate market sizing and growth projections to assess portfolio companies and acquisition targets.
    • Medical Technology Distributors : Regional distributors and healthcare suppliers need GCC market intelligence to identify demand hotspots, negotiate with manufacturers, and optimize inventory management.
    • Healthcare Consultants & Analysts : Consulting firms and research organizations require GCC-specific ECMO market data to support client advisory work, feasibility studies, and strategic healthcare planning initiatives.

    Key Companies in the GCC Countries ECMO Machines Market

    CompanyHQOwnershipStrongest segments
    GETINGESwedenPublic CompanyAcute Care Therapies,Surgical Workflows,Life Science,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
    FRESENIUS MEDICAL CARE AGGermanyPublic CompanyDialysis services (outpatient and in-hospital ESRD/acute),Dialysis machines, cyclers, and water treatment systems,Dialysis consumables and solutions,
    LIVANOVA PLCUnited KingdomPublic CompanyCardiopulmonary (heart-lung machines, oxygenators, autotransfusion, perfusion tubing, cannula, services),Neuromodulation (VNS Therapy for epilepsy and depression, aura6000 development),
    NIPROJapanPublic CompanyDialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products, functional products,Pharmaceutical-Related (CDMO for injectables and oral drugs, kit products),
    WEIGAO GROUP CO., LTD.ChinaPublic CompanyMedical Device Products (infusion, clinical nursing, perioperative, urinary, rehab, extracorporeal circulation),Orthopedic Products (spine, joint, trauma, sports medicine, bone repair, spinal endoscope),Pharma Packaging Products (prefilled systems, packaging consumables, automatic drug delivery),
    ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
    MICROPORT SCIENTIFIC CORPORATIONChinaPublic CompanyCardiovascular Devices,Orthopedics Devices,Cardiac Rhythm Management,

    GETINGE

    Getinge is a Swedish public company founded in 1904 that employs 11,754 people and operates in the medical technology sector.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees specializing in medical devices and healthcare solutions.

    TERUMO CORPORATION

    Terumo Corporation is a Japanese public company established in 1921 with 30,591 employees, operating in the medical device and healthcare industry.

    FRESENIUS MEDICAL CARE AG

    Fresenius Medical Care AG is a German public company founded in 1996 with 108,165 employees, providing dialysis and renal care services globally.

    LIVANOVA PLC

    LivaNova PLC is a United Kingdom-based public company founded in 2015 with 3,300 employees, focused on neuromodulation and cardiac surgery solutions.

    NIPRO

    Nipro is a Japanese public company established in 1947 with 38,593 employees, manufacturing medical devices and pharmaceutical products.

    WEIGAO GROUP CO., LTD.

    Weigao Group Co., Ltd. is a Chinese public company founded in 1988 with 13,307 employees, specializing in medical device manufacturing.

    ABBOTT

    Abbott is a United States-based public company founded in 1888 with 115,000 employees, operating across diagnostics, medical devices, nutrition, and pharmaceuticals.

    MICROPORT SCIENTIFIC CORPORATION

    MicroPort Scientific Corporation is a Chinese public company established in 1998 with 6,547 employees, developing and manufacturing medical devices.

    Reasons to Buy this Report

    • Market-Specific Insights : Gain detailed understanding of GCC-specific ECMO adoption patterns, regulatory requirements, and clinical preferences that differ from global market trends.
    • Competitive Intelligence : Identify key players, market share distribution, and competitive strategies specific to GCC countries to inform market entry or expansion decisions.
    • Investment & Growth Opportunities : Discover high-potential segments within GCC nations, including emerging hospitals, specialized centers, and underserved markets with growth potential through 2030.
    • Regulatory & Reimbursement Clarity : Understand GCC-specific regulatory frameworks, healthcare policies, and reimbursement mechanisms that impact ECMO device adoption and pricing strategies.
    • Strategic Planning Data : Leverage accurate market sizing, CAGR projections, and demand forecasts for GCC countries to develop targeted business strategies and resource allocation plans.

    Frequently asked questions

    What is the current market size of ECMO machines in Rest Of Europe?

    Rest Of Europe's ECMO machines market is estimated at $52.05 million in 2025, based on verified market data.

    What is the projected market size for ECMO machines in Rest Of Europe by 2030?

    Rest Of Europe's ECMO machines market is forecast to reach $67.98 million by 2030, representing significant growth over the five-year period.

    What is the growth rate of the ECMO machines market in Rest Of Europe?

    Rest Of Europe's ECMO machines market is growing at a compound annual growth rate of 5.5% from 2025 to 2030.

    What factors are driving ECMO market growth in Rest Of Europe?

    Rest Of Europe's ECMO market growth is driven by aging populations, rising prevalence of cardiac and pulmonary diseases, improved healthcare infrastructure, and increased clinical adoption of ECMO protocols in critical care settings.

    How does Rest Of Europe's ECMO market compare to other European regions?

    Rest Of Europe represents a significant segment of the broader European ECMO market, with steady growth at 5.5% CAGR and substantial market value, contributing meaningfully to the continent's overall extracorporeal membrane oxygenation market expansion.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size of the ECMO machines market. Exhaustive secondary research was done to collect information on the ECMO market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the ECMO market.

    Secondary Research

    This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the ECMO market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the ECMO market. Primary sources from the demand side included hospitals, academic & research institutions, specialty clinics, researchers, lab technicians, purchase managers, and stakeholders in corporate & government bodies.

    The following is a breakdown of the primary respondents:

    ECMO Machines Market

    Note 1: C-level primaries include CEOs, COOs, and CTOs.

    Note 2: Others include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ECMO market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    ECMO Machines Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ECMO machines and components. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    An ECMO machine acts as an artificial heart and lung for a patient whose heart or lungs cannot provide enough blood flow or oxygen into the blood. ECMO is used after other methods of supporting the heart and lungs do not work. The goal of ECMO is to let the heart and lungs recover while the patient is supported by the ECMO machine.

    Stakeholders

    • Manufacturers of ECMO Machine Products and Related Devices
    • Suppliers and Distributors of ECMO Machine Devices
    • Hospitals, Clinics, and Medical Colleges
    • Medical Device Procurement Agencies
    • Government Bodies/Municipal Corporations
    • Business Research and Consulting Service Providers
    • Venture Capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the oxygen concentrators market based on product, modality, patient type, application, end user, and region  
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall oxygen concentrators market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the oxygen concentrators market in six regions, namely, North America (US and Canada), Europe (Germany, UK, France, Spain, Italy, and Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), Middle East & Africa, and GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full ECMO Machines Market Report

    Full forecast, segment splits, and company analysis for all ECMO Machines Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status